Samir Rashmikant Patel - Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Samir Rashmikant Patel since 12/7/2024

Holdings reported by Samir Rashmikant Patel for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 3.03M $3.39M $1.12 Mar 20, 2025 PranaBio Investments LLC
Ordinary Shares, par value $0.0001 per share 5.25B $3.15M $0.00 Jan 3, 2025 PranaBio Investments LLC
Warrants (Right to Buy) 419M $503K $0.00 Dec 2, 2024 PranaBio Investments LLC Ordinary Shares, par value $0.0001 per share
Series A Warrants (Right to Buy) 406K $455K $1.12 Mar 6, 2025 PranaBio Investments LLC American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy) 406K $455K $1.12 Mar 6, 2025 PranaBio Investments LLC American Depositary Shares representing Ordinary Shares
Ordinary Shares, par value $0.0001 per share 91.4M $54.8K $0.00 Jan 3, 2025 Direct
American Depositary Shares representing Ordinary Shares 45.7K $51.2K $1.12 Mar 20, 2025 Direct
Ordinary Shares, par value $0.0001 per share 3.41B Jun 30, 2024 PranaBio Investments LLC
Ordinary Shares, par value $0.0001 per share 91.4M Jun 30, 2024 Direct
Stock Option (Right to Buy) 225K Mar 20, 2025 Direct American Depositary Shares representing Ordinary Shares

Transactions reported by Samir Rashmikant Patel for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.